Skip to main content
OpenTrials

Clinical trial condition

Influenza Immunisation

Explore clinical trials studying Influenza Immunisation. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Influenza Immunisation trial results

Completed

Flublok or Fluzone With Advax-CpG55.2 or AF03

NCT03945825

Conditions
Infections, Influenza, Influenza Immunisation, +6 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland Baltimore - School of Medicine - Medicine Baltimore, Maryland, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

NCT04451954

Conditions
Healthy Volunteers, Infections, Influenza Immunisation, +6 more
Locations
  • Investigational Site Number 8400003 San Diego, California, United States
  • Investigational Site Number 8400002 Melbourne, Florida, United States
  • Investigational Site Number 8400004 Orlando, Florida, United States
  • Investigational Site Number 8400001 Peoria, Illinois, United States
View Trial Details
Completed

Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

NCT03312231

Conditions
Animal Diseases, Avian Influenza, Bird Diseases, +9 more
Locations
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
  • Duke Vaccine and Trials Unit Durham, North Carolina, United States
View Trial Details
Completed

2013/2017 H7N9 Prime-Boost Interval

NCT03589807

Conditions
Animal Diseases, Avian Influenza, Bird Diseases, +9 more
Locations
  • Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

2017 A/H7N9 IIV Revaccination

NCT03738241

Conditions
Animal Diseases, Avian Influenza, Bird Diseases, +9 more
Locations
  • Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland Baltimore - School of Medicine - Medicine Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Age and Response to Flu Vaccines

NCT03328325

Conditions
Infections, Influenza, Influenza Immunisation, +6 more
Locations
  • Rochester General Hospital - Infectious Disease Unit Rochester, New York, United States
  • University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases Rochester, New York, United States
View Trial Details
Completed

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

NCT03682120

Conditions
Animal Diseases, Avian Influenza, Bird Diseases, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States
  • Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC) Nashville, Tennessee, United States
View Trial Details
Completed

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

NCT03318315

Conditions
Animal Diseases, Avian Influenza, Bird Diseases, +10 more
Locations
  • University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States
  • Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States
  • Vanderbilt University Medical Center - Infectious Diseases Nashville, Tennessee, United States
View Trial Details

Related conditions